Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma

Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma

Abstract Background Lung cancer is reported to be the leading cause of death in males and females, globally. Increasing evidence highlights the paramount importance of Lactate dehydrogenase D (LDHD) in different types of cancers, though it’s role in lung adenocarcinoma (LUAD) is still inadequately e...

Full description

Bibliographic Details
Main Authors: Yu Zhang, Tianyi Zhang, Yingdong Zhao, Hongdi Wu, Qiang Zhen, Suwei Zhu, Shaoshuai Hou
Format: Article
Language:English
Published: BMC 2023-08-01
Series:BMC Cancer
Subjects:
Lactate dehydrogenase D
Lung adenocarcinoma
The Cancer Genome Atlas
Biomarker
Prognosis
Immune infiltration
Online Access:https://doi.org/10.1186/s12885-023-11221-6

Internet

https://doi.org/10.1186/s12885-023-11221-6

Similar Items